---
$id: https://graph.org.ai/products/commodity/51361928
$type: Product
source: UNSPSC
code: "51361928"
title: "Amobarbital sodium"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Amobarbital sodium

**UNSPSC Code**: 51361928
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C11H17N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G0313KNC7D, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, monosodium salt but more generally known as amobarbital sodium, which bears US NIH Compound Identifier 6149. European Medicines Agency schedules Amobarbital sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00498MIG. Most nations, for tariff and trade purposes, schedule amobarbital sodium under HS 29335300. As of Q4 2014, AMOBARBITAL SODIUM remains US FDA's Preferred Term for this commodity. Amobarbital sodium bears US NLM identifiers UMLS ID C0037479 and NCI Concept Code C76524. SMILES: CCC1(C(=O)NC(=O)[N-]C1=O)CCC(C)C.[NA+].

